Vaccines independent medical education
GSK Vaccines: Support for Independent Medical Education
Independent Medical Education (IME) projects eligible for GSK Vaccines’ support via this application process include educational activities in general vaccinology or specific disease areas in which GSK Vaccines has marketed products.
For funding requests targeting a single country, local GSK offices should be contacted.
For US-based organizations requesting grant funding to support IME activities for US-based healthcare professionals, different guidelines apply and this process is not applicable. Please visit https://www.partnersinknowledge.com/GSKCenterforMedicalEducation for details.
The target recipients of the IME supported by this program should come from a broad international audience.
Recipient programs will develop the knowledge and practice of healthcare professionals in order that they can make the most appropriate curative or preventive treatment decisions for their patients.
GSK-funded IME activities are supported through funding at arm's-length by GSK. This means free from GSK influence on content development and faculty, participant and logistic selection. IME programs developed in this independent way provide a balanced perspective on the subject matter, putting the patient first. Organizations will be assessed according to defined criteria (below).
Travel Grants: Funding to support the travel and accommodation of attendees to reputable and renowned scientific meetings should be requested through the GSK Vaccines “Support for Travel Sponsorship for global/international IME activities or scientific congresses” request process.
Areas of interest for Independent Medical Education
GSK Vaccines has identified areas of interest where we and others have seen gaps in medical education related to disease areas where GSK has marketed products, as well as in general areas of vaccinology.
These are shared to enable organizations that have the skills, capability and credentials to deliver high-quality medical education to submit requests for funding from GSK to support such programmes.
Criteria for Independent Medical Education
GSK Vaccines will evaluate requests for funding based on essential criteria which include:
- Assessment of the type of organization requesting funding (Academic institution that trains healthcare professionals/ medical education charity that educates healthcare professionals/ patient group/ professional medical or scientific association or society/ healthcare service provider that employs healthcare professionals)
- Evidence of complete independence from any promotional activities related to GSK
- Absence of Conflicts of Interest in delivering medical education and in receiving funding from GSK
- Agreement from the recipient programme to be subject to potential independent audit to review quality of education delivered and use of funds provided.
Other local requirements and legislation related to medical education will also be considered.
Contact for Independent Medical Education
Should your organization wish to seek funding in any of the areas of interest, please contact us using our dedicated mailbox for requests (GSK.VaccinesIME@gsk.com) managed within Worldwide Vaccinology, Vaccine Education and Medical Training. Details of the process for submissions will be provided following initial contact.
Timelines for Independent Medical Education Grant Requests
Please note that Grants requests will be reviewed twice a year, in June and in November. Hence, for all IMEs to be developed and done between Feb 2021 to July 2021, the deadline for request submissions is 15 November 2020, for the all IMEs to be developed and done between August 2021 to January 2022, the deadline for request submissions is 15 May 2021.
Areas of Interest for Independent Medical Education
- Herpes Zoster disease awareness
- The epidemiology, clinical burden and public health impact of Herpes Zoster (HZ) disease
- Awareness of HZ complications and secondary health outcomes
- Understanding the underlying risk drivers for HZ, including immunosuppression as a consequence of age, underlying disease or immunosuppressive therapies/treatment
- Health care provider attitudes towards HZ, and the importance of prevention and vaccination as a key tool in preventing HZ
- Understanding potential barriers to HZ vaccination in older adults and those at increased risk due to underlying disease or immunosuppressive therapies/treatment or co-morbid conditions
- Effectiveness, impact and safety of HZ vaccination programs
- Effective introduction, implementation, and maintenance of effective HZ vaccination programs
- Effective communication with regards to reactogenic vaccines from Health Care Professional (HCP) to patients
Meningococcal meningitis prevention
- Value of meningococcal vaccination
- Effectiveness and impact of MenB vaccination programs
- Duration of protection and booster vaccination
- Beyond MenB protection with MenB vaccines
- Vaccination strategies with MenB and MenACWY
Measles, mumps, rubella and varicella virus prevention
- Burden of moderate to severe varicella disease – (hospitalisations, complications, Congenital Varicella Syndrome, sequelae)
- Social impact of varicella disease for parents, workers, employers
- The impact/benefit of vaccinating against varicella (both medical impact and direct/indirect cost-effectiveness)
- Education about benefits and convenience of concomitant varicella and zoster vaccination
Pediatric primary combination vaccination
- Diphteria, Tetanus, Polio, Hib Control
- Role of DTP combination vaccines in Hep B control
- Role of IPV in polio end game strategy
- Primary Vaccination in neonates including pre-terms
- Pertussis Prevention strategies
- Pertussis Maternal immunization
- Pertussis burden in neonates, older adults and other risk groups
- Vaccination impact on Pertussis carriage and transmission?
Pediatric pneumococcal diseases prevention
- The burden of pediatric pneumococcal disease
- Efficacy, impact and safety of pneumococcal conjugate vaccines (PCV)
- Experience with implementation of pneumococcal conjugate vaccines
- Cost-effectiveness of pneumococcal vaccines
Rotavirus Prevention and Disease control
- Rotavirus Gastroenteritis is more than just diarrhoea - Appreciating true burden of rotavirus disease and need for its prevention through vaccination in children under 5 years of age
- HCPs play an important role as advocates in raising awareness and effectively counselling parents on the importance of Rotavirus vaccination for the prevention of RVGE: Sharing experience from Health Care Providers daily practices
- Understanding the Full Public Health Value of Rotavirus vaccination – Moving towards UMV approach for higher coverage of RV vaccination and better disease control
- Recognising the importance of Early vaccination against Rotavirus disease and valuing its significant impact
Influenza (Flu) virus prevention
- Childhood seasonal influenza vaccination: awareness, coverage, vaccines effectiveness, burden of disease, in North America, Europe and International.
- Burden of disease of seasonal influenza in pregnant woman, and infants (worldwide) and experience with seasonal influenza vaccination (TIV and QIV)
- Childhood and school based influenza vaccination programs and strategies (Introduction of new programs, impact of vaccination, herd effect/indirect protection)
- Influenza burden of disease and impact of vaccination against different flu strains in US, Europe and International
- Pandemic preparedness
Human Papilloma Virus (HPV) prevention
- Cervical Cancer Disease awareness in Asia and Latin America
- Effectiveness and safety of Cervical Cancer Prevention through vaccination
- Effective introduction and maintenance of vaccination programs
- 1-dose schedule
- Head and Neck Cancer
Combined Hepatitis A and Hepatitis B vaccine
- Benefits of using a combined hepatitis A and B vaccine
Hepatitis B Virus (HBV) prevention
- The public health impact of hepatitis B vaccines
- Identification of gaps in implementation of hepatitis B recommendations
- Use of monovalent hepatitis B vaccines vs combination vaccines
Hepatitis A Virus (HAV) prevention
- Updated epidemiology: shifting endemicity and low endemic countries
- Awareness of recommendations and target populations for vaccination
- Impact of hepatitis A vaccination programmes
General vaccination topics
- Societal and economic barriers for providers and population to vaccine uptake for all ages (in particular for adolescents, adults and older adults)
- Innovative solutions for educational activities aiming to increase vaccine awareness and acceptance in all ages,
- Behavioural science and behavioural economics applied to vaccination
- Impact of infectious diseases (IDs) and vaccine preventable IDs in older adults’ morbidity and mortality, and in relation to the frailty index
- Vaccination strategies including new technologies to support healthy ageing and for overcoming the age-related decline in immunity
- The role and value of vaccine solutions beyond the simple cost/benefit assessment of vaccines to support life-course immunisation and healthy ageing
- Impact of communication interventions to HCPs or general public on vaccine uptake using digital platforms and channels
- Vaccine related education for Medical and Health Science schools or post-graduate courses
- Vaccine related education in primary and secondary schools
- Materials, innovative tools to help people of any age understand vaccination, including serious gaming
- Challenges and solutions to implement life course immunisationVaccination as contribution to healthy lifestyle, multidisciplinary approach to prevention.
Find out more
Vaccines travel sponsorship
Support for travel sponsorship for global/international independent medical education activities or scientific congresses
Respiratory independent medical education
Support for severe asthma independent medical education
Compassionate use (Expanded access)
Our policy explains our position and criteria for assessing requests and provides a link for health care professionals’ requests.
We are changing the way we work to further embed our values in everything we do, including the way we research, develop, sell and market our products